Reproductive Health

Wisp Expands into Fertility; Enhancing Access to Comprehensive Reproductive Care

Wisp, a company working in sexual and reproductive health, has taken a step forward by launching a new fertility vertical aimed at supporting women through every stage of their reproductive health journey. Through this strategic move Wisp wants to make healthcare more affordable and accessible for women, especially those facing challenges in conceiving. Fertility is a crucial aspect of women’s reproductive health,…

Founder Gina Bartasi Returns as CEO to Lead Kindbody’s Next Phase of Growth

In a significant leadership shift, Gina Bartasi, the founder and executive chairman of Kindbody, has returned to her role as CEO to steer the company through its next phase of growth. Kindbody is known as a leading national fertility clinic network in the U.S. and global family-building benefits provider. Kindbody was founded by Bartasi in late 2018, and has grown into the…

YourChoice Therapeutics Completes Phase 1a Clinical Study for Its Hormone-Free Male Birth Control Pill

YourChoice Therapeutics has achieved a significant milestone by completing its first-in-human clinical study for YCT-529, the pioneering hormone-free male birth control pill. Announced at the 2024 BIO International Convention, this development marks a breakthrough in contraceptive options, particularly for men. “We’re one step closer to delivering the world’s first male birth control pill,” said YourChoice Therapeutics Chief Science Officer Nadja Mannowetz. The…

Rhea Launches Global Reproductive Health Services Company and Acquires Embryonics; Adds Funding from Thiel Capital

Rhea, a global reproductive health services company, has officially launched, aiming to improve fertility journeys for modern families. The launch coincides with a follow-on funding round led by Thiel Capital, aimed at expanding Rhea’s global footprint and service offerings. Rhea is creating an end-to-end reproductive health ecosystem, connecting prospective families across Asia, North America, and Europe. The company’s services are centered around…

What’s New in Femtech This Week? (May 30, 2024)

Every Thursday we send out a curated newsletter on all things femtech and women’s health innovation. This is an excerpt from the latest edition. If you’d like to subscribe, you can do so at the bottom of this page. Highlights Natural Cycles secures $55M Series C funding to accelerator growth ahead of possible IPO. Gameto secures $33M in Series B funding to advance novel IVF treatments. Male reproductive…

Male Reproductive Health Startup Posterity Health Raises $6M to Fund Expansion and Technology Acceleration

Posterity Health, the “center of excellence for male reproductive health”, announced the closing of a $6M round of financing led by FCA Venture Partners and supported by Distributed Ventures and WVV. The incremental funding will be used to accelerate the development of the Posterity Health Male Management Platform (MMP), launch new services, and expand the executive team. Posterity Health’s goal is to…

Natural Cycles Secures $55 Million Series C Funding to Accelerate Growth Ahead of Possible IPO

Natural Cycles, a women’s health company known for developing the world’s first birth control app, has announced the successful closure of its $55 million Series C financing round. The round was led by Lauxera Capital Partners, with additional participation from Point72 Private Investments and a revolving debt facility provided by J.P. Morgan. Natural Cycles, co-founded in 2013 by Dr. Elina Berglund Scherwitzl…

Gameto Secures $33M in Series B Funding to Advance Novel In Vitro Fertilization Treatments

Gameto, a biotech firm dedicated to women’s health, has announced the successful closure of a $33 million Series B financing round. This round, which exceeded initial targets, was led by Two Sigma Ventures and RA Capital, with participation from existing investors such as Insight Partners, Future Ventures, and BOLD Capital Partners. New investors include Olivia Walton’s Ingeborg Investments, Stacey Bendet Eisner, and…